Researcher working in a lab on a new immunotherapy for lung cancer treatment option.

Adjuvant Immunotherapy Atezolizumab Approved for Lung Cancer

By Rachel Ernst | October 30, 2021

The FDA has granted approval for atezolizumab as adjuvant immunotherapy for non-small cell lung cancer treatment. Atezolizumab is the first immunotherapy drug to be approved by the FDA for use as an adjuvant indication.

Female oncologist holding white lung cancer awareness month ribbon

Lung Cancer Awareness Month – How to Show Your Support

By Morgan Barnhardt | October 28, 2021

Every year, the month of November is Lung Cancer Awareness Month. Bringing awareness to this cancer is vital for finding a cure. Find out ways you can help support those with lung cancer and their advocates.

Adjuvant Immunotherapy Atezolizumab OK'd in Non-Small Cell Lung Cancer